Insider · CIK 0001420987
James A Schoeneck
Files at KYNB (KYNTRA BIO, INC.), CLDI (Calidi Biotherapeutics, Inc.). First filing Mar 24, 2025, latest Aug 25, 2025.
James A Schoeneck files SEC Form 4 as director at KYNB (KYNTRA BIO, INC.), and also at CLDI (Calidi Biotherapeutics, Inc.). Since Mar 24, 2025, James A Schoeneck has reported 3 open-market buys worth $375k and 0 open-market sells worth $0, the latest filed on Aug 25, 2025.
A track record needs three past buys with six months of prices behind them; James A Schoeneck has 0, so none is measured yet.
The newest scored trade: bought $150k of CLDI on Aug 21, 2025, filed Aug 25, 2025, scored 69 (notable).
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
KYNB: KYNTRA BIO, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CLDI: Calidi Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 69Notable | Calidi Biotherapeutics, Inc. | $150k 75,000 shares | +6614% | 0% from low-96% from high | |
| 53Moderate | KYNBbuy KYNTRA BIO, INC. | $119k 23,567 shares | +146% | +3% from low-73% from high | |
| 43Moderate | KYNTRA BIO, INC. | $105k 300,000 shares | +407% | - |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | POpen-market purchase Common Stock | +75,000 | $2.00 | $150k | 76,134 | Aug 25, 2025 |
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | POpen-market purchase Warrant (right to buy)derivative | +75,000 | - | - | 75,000 | Aug 25, 2025 |
| Jul 9, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +164,493 | $0.00 | $0 | 164,493 | Jul 15, 2025 |
| Jun 30, 2025 | KYNB KYNTRA BIO, INC. | POpen-market purchase Common Stockindirect: By Trust | +23,567 | $5.07 | $119k | 39,666 | Jul 2, 2025 |
| Jun 4, 2025 | KYNB KYNTRA BIO, INC. | AGrant or award Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 6, 2025 |
| Mar 20, 2025 | KYNB KYNTRA BIO, INC. | POpen-market purchase Common Stockindirect: By Trust | +250,000 | $0.35 | $88k | 323,722 | Mar 24, 2025 |
| Mar 21, 2025 | KYNB KYNTRA BIO, INC. | POpen-market purchase Common Stockindirect: By Trust | +50,000 | $0.34 | $17k | 373,722 | Mar 24, 2025 |
| Sep 20, 2024 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +20,217 | - | - | 20,217 | Oct 15, 2024 |
Questions about James A Schoeneck
Answered from the filings on this page, as of the latest one.
Is James A Schoeneck buying or selling?
Not in the last 12 months. James A Schoeneck's latest open-market trade on SEC Form 4 was bought $150k of CLDI on Aug 21, 2025.
How did James A Schoeneck's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James A Schoeneck has 0.
Where does James A Schoeneck file Form 4?
James A Schoeneck has filed Form 4 at KYNB (KYNTRA BIO, INC.); CLDI (Calidi Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.